Women less likely to get care for potentially fatal heart condition, study finds
Researchers found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis.
Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds.
Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness.
The condition is more common in elderly people.
It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery.
If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death.
The analysis suggests some people are less likely to receive this treatment.
Experts from the University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England.
Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve.
Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods.
Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients.
South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre.
Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis.
'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice.
'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.'
Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which supported the research, and consultant cardiologist, said: 'This study of over 150,000 GP records has unveiled disparities in access to aortic valve treatment for women, south Asian and black people, and people living in more deprived communities.
'We don't yet have the full picture, but these findings are concerning and we need more research to understand what is driving the differences seen.
'This will be crucial to enable action to address any underlying causes stopping some people from having access to the heart valve treatment and care they need, when they need it.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 days ago
- Yahoo
Legionella just one of many HVAC risks, microbiologist says
This story was originally published on Facilities Dive. To receive daily news and insights, subscribe to our free daily Facilities Dive newsletter. The Legionnaires' disease outbreak last month in New York City reminded people of the risk inadequately managed HVAC systems pose. Four people died and dozens were sickened by contamination that was spread through commercial building cooling towers in Harlem, city health officials said. But HVAC systems can pose risk more routinely than that if filters aren't cleaned regularly, malfunctioning units release vapors from cleaning agents or if the systems cause indoor air to dry out too much, says Primrose Freestone, senior lecturer in clinical microbiology at the University of Leicester in the U.K. HVAC systems are likely behind many cases of sick building syndrome, Freestone says in an essay published by The Conversation, a nonprofit news organization focusing on academic topics. Buildings are considered 'sick' if occupants experience headaches, dizziness, congestion and other symptoms after spending time indoors and other factors are ruled out. 'It's suspected that one cause of sick building syndrome is malfunctioning air conditioners,' Freestone says. 'When an AC unit isn't working properly, it can release allergens, chemicals and airborne microorganisms into the air that it would normally have trapped.' Freestone pointed to a 2021 study that found AC units can be the source of infectious microbes that cause a range of illnesses, from the common cold to pneumonia. Contaminated ventilation is a particularly big problem in hospitals because HVAC systems in these settings are prone to contamination from fungal pathogens like Aspergillus, Penicillium, Cladosporium and Rhizopusspecies, and many people there are already immunocompromised or otherwise susceptible to illness. 'Fungal infections can be serious in vulnerable patients,' she says. 'For example, Aspergillus causes pneumonia, abscesses of the lungs, brain, liver, spleen, kidneys and skin, and can also infect burns and wounds.' Systems that dry out air too much pose a problem because dry air can make people prone to infection, she says. 'Low-humidity environments can dry out the mucus membranes in your nose and throat,' she says. 'This can affect how well they prevent bacteria and fungi from getting in your body – and can leave you more vulnerable to developing a deep-tissue infection of the sinuses.' HVAC cleaning is crucial to controlling pathogen spread but the cleaning products themselves can be a problem if the system isn't working properly, she says. 'Malfunctioning air conditioners can … release chemical vapours from AC cleaning products,' she says. All this sharpens the point of adequate HVAC maintenance, she says. 'Ensuring good AC maintenance is essential in preventing air-conditioner-acquired infections,' she says. Recommended Reading Legionella outbreak puts facility managers on front lines Sign in to access your portfolio
Newsweek
5 days ago
- Newsweek
The Secret to Slowing Down Aging Could Come From a Surprising Source
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new study suggests that an insect could hold clues to slowing the pace of biological aging. Researchers at the University of Leicester have discovered that jewel wasps can dramatically extend their lifespans by undergoing a natural developmental pause known as diapause. The findings, published in the journal Proceedings of the National Academy of Sciences, reveal that this pause slows the "epigenetic clock"—a molecular marker of aging that tracks chemical changes in DNA. The species is an emerging model for aging research because, unlike many other insects, it has a functioning DNA methylation system similar to humans. When mothers were exposed to cold and darkness, their larvae entered diapause, effectively pressing a biological "pause button." Stock image: A wasp. Stock image: A wasp. Photo by Marta Fernandez / Getty Images The results were striking: wasps that had undergone diapause lived more than a third longer as adults. Their molecular markers of aging ticked 29% more slowly than those of wasps that developed normally. "We usually think of aging as life slowly falling apart, like a bike rusting in the rain," study author Eamonn Mallon told Newsweek in an email. "But our study hints that aging might be more like a badly planned journey, with checkpoints you can actually delay. If a tiny wasp can hit pause on its biological clock by going into dormancy, maybe there are ways to do something similar in more complex animals. "It's early days, but it's definitely food for thought, especially if you're hoping to age a little more gracefully." Why It Matters Understanding how and why organisms age remains one of science's biggest challenges. By showing that early-life environmental factors can slow the pace of molecular aging, the Leicester team has opened new avenues for anti-aging research. The study's evidence that the epigenetic clock can be slowed in an invertebrate raises the possibility that environmental factors—or eventually medical interventions—might one day delay biological aging in humans. What to Know The jewel wasp's diapause was triggered under controlled conditions of darkness and cold, mimicking seasonal survival strategies. Scientists found that even after normal development resumed, the benefits persisted: the wasps' slower pace of epigenetic aging was linked to conserved biological pathways, including those involving insulin and nutrient sensing. These same pathways are already the target of several human anti-aging studies. This makes jewel wasps a rare invertebrate model capable of bridging laboratory research with potential human health applications. "When people hear 'wasps,' they usually imagine something buzzing angrily around a picnic," Mallon told Newsweek. "Nasonia couldn't be further from that, it's tiny, just a couple of millimeters long and completely harmless to humans. You'd struggle to notice one, let alone get stung." Mallon noted that for flies, Nasonia is "pure nightmare fuel." He said it was a, "parasitoid wasp, which means the female drills into a fly pupa, injects it with venom to kill it and then lays her eggs inside," he said. "Her offspring grow up happily feeding on the corpse from the inside out. So while I don't need to worry about getting stung, the flies definitely should." What People Are Saying "This is more than an academic curiosity," Mallon said. "We're starting to explore how these findings might actually help in the search for interventions that slow ageing, or improve late-life health. "That's the idea behind Vitality Labs, a new initiative aimed at turning insect models like Nasonia into powerful tools for drug discovery. [...] "The hope is to take insights from tiny wasps and build something with big impact." What's Next The findings position jewel wasps as a key model for testing whether targeted manipulation of the epigenetic clock can improve health and lifespan.
Medscape
29-07-2025
- Medscape
Looking Back and to the Future: Inspiration at ADA 2025
This transcript has been edited for clarity. Hi, I'm just back from Chicago where I attended the annual ADA meeting. I'm going to try to go through some of the parts of the meeting that I found interesting. Now, in these talks, I'm not going to cover everything, and there were many other topics discussed. I apologize in advance for not being able to discuss everything, but I think that there are some things that are clinically very relevant, things that I take home to my practice that I wanted to share with you. First, I wanted to give you an overview, and there were two overview lectures that I thought were really important. The first one was a lecture given by Dr Venkat Narayan. He was the recipient of the Distinguished International Service in the Cause of Diabetes Award, and basically what he talked about [was] diabetes care in low- to middle-income countries. This is really important to me, because around the world, we're really not providing adequate diabetes care. Obviously, in parts of the United States, like where I work in East Los Angeles where patients are under-resourced, we often don't have the kind of resources we need to provide adequate care. Diabetes affects 828 million people globally. The highest global prevalence is found in India with 213 million people with diabetes, then China with 143 million, and the US with 42 million. Those numbers alone are pretty staggering, but what bothers me the most is that half of all the people with diabetes remain don't have the ability to treat their diabetes with many of the drugs that I think we tend to take for granted in this country. Diabetes is now the fourth leading cause of disability and the ninth leading cause of death worldwide. All-cause mortality from diabetes has decreased in high-income countries, but we haven't seen that kind of improvement in these low- to middle-income countries. If you look at the coverage of glucose-lowering medications, they're available in about 50% of the cases in those countries; antihypertensive medicine in 41%; and cholesterol-lowering medication in 7%. Fewer than 1 in 10 people with diabetes in these low- to middle-income countries receive coverage that is consistent with guideline-based comprehensive diabetes management. There's a large amount of work to be done, and I think that one of the things that Dr Narayan talked about was the need for early detection and prevention of diabetes, which would help, and also the use of mobile health. Many of these countries do have mobile phones, and there was a recent study that was done, called The Center for cArdiometabolic Risk Reduction in South Asia, where they did see a reductionin a number of variables — including A1c, blood pressure, and LDL cholesterol — using this mobile health intervention. Another thing he discussed was the gap in diabetes research, which I see all the time because there are places where we've really studied different populations. We know a large amount about Pima Indians in the United States, but there are also places, like in Asia,where diabetes is different. I think we all know — those of us who treat different ethnic populations — that we see varying characteristics of diabetes. Unfortunately, much of the research that has been done is still done in European populations. Even though 85% of diabetes occurs in non-Europeans, only about 3%-4% of research is done on non-European populations. When I'm dealing with my population, which is largely Latino in East LA, I realize the limits of what we know, particularly in terms of such diseases as type 1 diabetes in this population, because nobody really knows the types of presentations of type 1 diabetes and what it looks like in terms of risk and prevention in this group. Next, there was the ADA President's Lecture, which was delivered by Dr Rita Kalyani. She's at Johns Hopkins University, but she's about to be the chief medical officer (CMO) of the American Diabetes Association. I think it's really nice to get a sense of her as she moves into the role of leading the ADA. In her lecture, she looked backward at where we've come. We've come a very long way, even in terms of my own career.I started with just finger sticks, and look where we've come since then. She also talked about the challenges. She, too, talked about the global prevalence of diabetes. She also talked about the aging diabetes population. As people live longer, they're more likely to get diabetes over time,and managing diabetes in older patients can be complicated. She talked about youth-onset type 2 diabetes, which is also increasing, and many of these patients don't have the kind of glycemic management we'd like them to have. She talked about endocrinology deserts and the fact that two-thirds of US counties lack endocrinologists, which basically means that we need to figure out how we can service more counties and areas as individual endocrinologists. There's a large need for not only endocrinologists but also all sorts of diabetes educators, who I think are very important to helping patients with diabetes in many of these areas. She talked about the low uptake of cardio- and kidney-protective therapies, and I think this is something that really should be adopted more and more in primary care where most of these patients are taken care of. I know it's possible to do. I know places where this is done actually quite intensively, but I think we need to expand it throughout the country so people are aware of the need to work with some of these newer agents in our population. Then, of course, we have the obesity epidemic in the United States, and we have many people who are overweight or obese and at risk for going on to develop diabetes. Then she talked about our collective future, really looking ahead at all the issues that we have facing us in the near term as well as in the long talked about all of us working together to try to change how diabetes care is delivered, improve access, and help people achieve their outcomes and do better with this disease. I found both of those lectures inspiring. I'm very excited to have Dr Kalyani as the new CMO of the American Diabetes Association, and I look forward to working with her in the years to come. Thank you.
